Back to Company Profile

MédiMabs is structured to analyze new needs that arise int he research world. To address such needs, the company can conducts a variety of R&D projects, develops new research tools and provides antibodies for which there is high demand.

Thanks to their vast experience and numerous connections to the investigation community in varied areas, the founders of MédiMabs have direct access to the newly-generated antibodies in research laboratories worldwide. Their involvement in the pharmaceutical and biotechnology sphere further enhances and facilitates the acquisition of licenses from the governing technology offices of the different research institutions.

Their hands-on use of antibodies in their own research activities allows them to better address issues involved in their own genomic and protemic projects as well as to resolve customer dissatisfaction such as lack of product availability, lack of selection, paucity of references, paucity of high quality application-specific notes. They are equipped to provide pertinent advice in the design of research projects involving antibody research.

MédiMabs offers the most competitive royalty-based compensation package for the licensing of research generated antibodies.

Targeted Marketing

MédiMabs collects and continuously updates databases of researchers which are used to market products to the researchers that use them. Through product specific flyers, targeted emails and individual mailings, researchers are continuously aware of the latest products and services offered by MédiMabs.